From: METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis
 |  | METTL3 expression |  |  | CYP19A1 expression |  |  |  | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Characteristics | Total (n = 84) | Low (n = 25) | High (n = 59) | χ2 | P value | Low (n = 26) | High (n = 58) | χ2 | P value | |||
Gender  Male  Female |  |  |  | 0.04314 | 0.8355 |  |  | 1.951 | 0.1624 | |||
66 | 20 | 46 | Â | Â | 18 | 48 | Â | Â | ||||
18 | 5 | 13 | Â | 8 | 10 | Â | Â | |||||
Age at surgery  ≥ 60  < 60 |  |  |  | 0.7921 | 0.3735 |  |  | 0.1442 | 0.7042 | |||
33 | 8 | 25 | Â | Â | 11 | 22 | Â | Â | ||||
51 | 17 | 34 | Â | Â | 15 | 36 | Â | Â | ||||
TNM stage | Â | Â | Â | 0.2847 | 0.5936 | Â | Â | 14.44 | 0.0001 | |||
 I-II | 30 | 10 | 20 |  |  | 17 | 13 |  |  | |||
 III | 54 | 15 | 39 |  |  | 9 | 45 |  |  | |||
TNM stage: T | Â | Â | Â | 0.1452 | 0.7032 | Â | Â | 6.641 | 0.0100 | |||
 T1-T2 | 58 | 18 | 40 |  |  | 23 | 35 |  |  | |||
 T3-T4 | 26 | 7 | 19 |  |  | 3 | 23 |  |  | |||
TNM stage: N | Â | Â | Â | 7.999 | 0.0047 | Â | Â | 10.36 | 0.0013 | |||
 N0 | 20 | 11 | 9 |  |  | 12 | 8 |  |  | |||
 N1-3 | 64 | 14 | 50 |  |  | 14 | 50 |  |  | |||
Tumor histology | Â | Â | Â | 0.2739 | 0.6007 | Â | Â | 2.553 | 0.1101 | |||
 SQC | 44 | 12 | 32 |  |  | 17 | 27 |  |  | |||
 ADC | 40 | 13 | 27 |  |  | 9 | 31 |  |  |